Ascendis Pharma (ASND) announced the commencement of trading of its ordinary shares on The Nasdaq Global Select Market, replacing the listing of American Depositary Shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASND:
- Ascendis Tracks YORVIPATH in Breast Milk: What Investors Should Know
- 2 Best ETFs to Buy in April 2026, According to Analysts
- Ascendis Pharma price target raised to $292 from $262 at BofA
- Ascendis Pharma Issues New Employee Warrants as Part of Long-Term Incentive Program
- Ascendis Pharma Reports Strong Week 52 COACH Trial Data for TransCon CNP and hGH Combo in Achondroplasia